http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#Head http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#assertion http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#provenance http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#pubinfo http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#assertion http://purl.obolibrary.org/obo/DOID_409 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_409 http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00744 http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#association http://www.w3.org/2000/01/rdf-schema#label "The use of Zileuton Extended-Release Tablets is contraindicated in patients with: Active liver disease or persistent hepatic function enzyme elevations greater than or equal to 3 times the upper limit of normal (>=3xULN) [see Warnings and Precautions (5) Use in Specific Populations (8.7) A history of allergic reaction to zileuton or any of the ingredients of Zileuton Extended Release Tablets (e.g., rash, eosinophilia, etc.). Active liver disease or persistent hepatic function enzyme elevations >=3 times the upper limit of normal. ( 4 5.1 History of allergic reaction to Zileuton or any of the ingredients of Zileuton Extended-Release Tablets. ( 4" http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00744 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#provenance http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#pubinfo http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#sig http://purl.org/nanopub/x/hasSignature X7+BvuEhn6t7Pam8pE9RWoXjVgYaYfbQ9BDFItywvs/blGatCdU5TMO9gR4W+6o73frnCoSPDSj4KmrVnMjtAOaEmK8lPjPe3BHj1eaTtQmvOxVJZ6QT++lEmuM4lqdfw/93RRcLHFIszw7g/1uIcG5xWupEHoJceKRDpFv7dzg= http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI http://purl.org/dc/terms/created 2021-08-25T13:58:13.360+02:00 http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY